Lucia Altucci Selected Research

Lucia Altucci Research Topics

Disease

101	Neoplasms (Cancer) 05/2022 - 05/2002
27	Leukemia 01/2021 - 05/2002
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2021 - 02/2004
12	Breast Neoplasms (Breast Cancer) 02/2021 - 04/2003
8	Carcinogenesis 01/2022 - 10/2003
8	Acute Promyelocytic Leukemia 04/2014 - 05/2002
6	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016 - 09/2009
5	Hypoxia (Hypoxemia) 12/2021 - 01/2014
4	Inflammation (Inflammations) 01/2022 - 01/2020
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 12/2010
4	Hematologic Neoplasms (Hematological Malignancy) 07/2020 - 09/2010
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2017 - 09/2010
3	Carcinoma (Carcinomatosis) 05/2022 - 10/2003
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 09/2012
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2014
2	Starvation 05/2022 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 03/2022
2	Ischemia 12/2021 - 03/2019
2	Neuroblastoma 12/2021 - 01/2018
2	Cardiotoxicity 01/2021 - 09/2016
2	Infections 01/2021 - 12/2020
2	Heart Failure 01/2021 - 01/2020
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 09/2014
2	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2018
2	Liver Neoplasms (Liver Cancer) 10/2018 - 08/2018
2	Mesothelioma 05/2008 - 10/2006
2	Genetic Translocation (Chromosomal Translocation) 02/2004 - 01/2004
1	Thrombosis (Thrombus) 07/2022
1	Methylenetetrahydrofolate reductase deficiency 07/2022
1	Squamous Cell Carcinoma of Head and Neck 05/2022
1	Adenocarcinoma 03/2022

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2003
24	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2005
13	Pharmaceutical PreparationsIBA 12/2021 - 10/2006
13	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 01/2005
12	ChromatinIBA 03/2021 - 01/2005
11	Biological ProductsIBA 02/2021 - 09/2004
11	Histones (Histone)IBA 12/2019 - 11/2006
10	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2012
10	EnzymesIBA 01/2020 - 05/2009
9	Sirtuin 1IBA 07/2022 - 01/2012
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2004
9	SirtuinsIBA 01/2020 - 09/2009
7	Hormones (Hormone)IBA 01/2021 - 04/2003
6	Histone DemethylasesIBA 01/2020 - 01/2014
6	LigandsIBA 04/2015 - 05/2002
6	RetinoidsIBA 04/2014 - 05/2002
6	Estrogens (Estrogen)FDA Link 12/2008 - 12/2003
5	Estrogen Receptor alphaIBA 02/2021 - 08/2004
5	MethyltransferasesIBA 01/2021 - 12/2010
5	Antineoplastic Agents (Antineoplastics)IBA 11/2019 - 07/2012
4	TubulinIBA 05/2022 - 05/2007
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
4	Vorinostat FDA Link 05/2019 - 05/2009
4	Histone Acetyltransferases (Histone Acetyltransferase)IBA 09/2014 - 06/2009
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2014 - 05/2002
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
3	CaspasesIBA 02/2021 - 01/2007
3	Estrogen ReceptorsIBA 02/2021 - 08/2006
3	CytokinesIBA 01/2021 - 11/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2014
3	Azacitidine (5 Azacytidine)FDA Link 02/2020 - 09/2014
3	Decitabine FDA Link 02/2020 - 09/2014
3	quinolineIBA 02/2020 - 03/2014
3	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2020 - 10/2005
3	Lysine (L-Lysine)FDA Link 12/2019 - 05/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 10/2005
3	romidepsin (FK228)FDA Link 09/2014 - 09/2010
3	entinostat (MS 275)IBA 07/2014 - 05/2009
3	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 02/2010 - 05/2002
3	Death Domain ReceptorsIBA 03/2009 - 01/2005
2	domatinostatIBA 04/2022 - 03/2022
2	SodiumIBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2022 - 12/2021
2	AntioxidantsIBA 08/2021 - 05/2013
2	regorafenibIBA 01/2021 - 06/2018
2	Insulin (Novolin)FDA Link 01/2021 - 04/2003
2	VaccinesIBA 01/2021 - 01/2017
2	UbiquitinIBA 07/2020 - 01/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2020 - 01/2020
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2013
2	MC1568IBA 05/2019 - 12/2008
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2019 - 04/2003
2	bisphenol AIBA 12/2017 - 12/2008
2	Oncogene Proteins (Oncogene Protein)IBA 11/2016 - 01/2005
2	benzamideIBA 01/2015 - 12/2012
2	sirtinolIBA 02/2010 - 04/2008
2	Piroxicam (Feldene)FDA LinkGeneric 05/2008 - 10/2006
2	Cisplatin (Platino)FDA LinkGeneric 05/2008 - 10/2006
2	Retinoic Acid Receptor alphaIBA 10/2005 - 02/2004
1	ResveratrolIBA 07/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022

Therapy/Procedure

41	Therapeutics 05/2022 - 05/2002
9	Drug Therapy (Chemotherapy) 04/2022 - 02/2004
4	Precision Medicine 01/2021 - 01/2017
3	Radiotherapy 01/2021 - 01/2017
2	Immunotherapy 01/2021 - 01/2018
2	Microbubbles 10/2018 - 08/2018